Peroxynitrite scavengers for the acute treatment of traumatic brain injury

被引:50
|
作者
Hall, ED [1 ]
Kupina, NC [1 ]
Althaus, JS [1 ]
机构
[1] Parke Davis Pharmaceut Res, Neurosci Therapeut, Ann Arbor, MI 48105 USA
关键词
D O I
10.1111/j.1749-6632.1999.tb08025.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent evidence has suggested that the superoxide and nitric oxide-derived reactive oxygen species peroxynitrite (ONOO-) may play a significant role in the acute pathophysiology of brain injury. One pharmacological mechanism by which ONOO--mediated damage might be interrupted is by the administration of scavenging compounds such as the thiol-containing compound penicillamine. In the present study, we examined the ability of either penicillamine (Pen) or the more brain penetrable penicillamine methyl ester (PenME) (0.01, 0.1, 1.0 or 10.0 mg/kg i.v. 5 min post-injury) to improve the early (1 hr) neurological recovery (grip score) of male CF-1 mice after a severe (900 g-cm; 50 g x 18 cm) injury. Pen produced a dose-related improvement in grip score. At 1.0 mg/kg, a +112% improvement was observed compared to vehicle-treated mice, and at 10.0 mg/kg, the increase was +168% (both, p < 0.05), PenME more potently improved the l-hr grip score, but the magnitude of the optimal effect (+96% at 0.1 mg/kg; p < 0.02) was no greater than that observed with Pen, which largely remains in the cerebral microvasculature. These results are consistent with a role of ONOO- in acute head injury, but suggest that microvascular scavenging may be of primary therapeutic importance during the early post-traumatic period.
引用
收藏
页码:462 / 468
页数:7
相关论文
共 50 条
  • [1] Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging
    Slemmer, J. E.
    Shacka, J. J.
    Sweeney, M. I.
    Weber, J. T.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2008, 15 (04) : 404 - 414
  • [2] TRAUMATIC BRAIN INJURY - ACUTE PATHOGENESIS AND TREATMENT
    SALAZAR, AM
    [J]. REVISTA ECUATORIANA DE NEUROLOGIA, 1995, 4 (1-2): : 22 - 30
  • [3] Pharmacologic treatment of acute traumatic brain injury
    Faden, AI
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (07): : 569 - 570
  • [4] Results of galantamine treatment in acute traumatic brain injury
    Johnson, Benjamin
    Sey, Michael Sai Lai
    Bhalerao, Shree
    [J]. PSYCHOSOMATICS, 2007, 48 (02) : 177 - 178
  • [5] Acute treatment of patients with severe traumatic brain injury
    Juratli, T. A.
    Stephan, S. E.
    Stephan, A. E.
    Sobottka, S. B.
    [J]. ANAESTHESIST, 2015, 64 (02): : 159 - 172
  • [6] Outcomes and costs of acute treatment of traumatic brain injury
    McGarry, LJ
    Thompson, D
    Millham, FH
    Cowell, L
    Snyder, PJ
    Lenderking, WR
    Weinstein, MC
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2002, 53 (06): : 1152 - 1159
  • [7] Progesterone in the clinical treatment of acute traumatic brain injury
    Stein, Donald G.
    Wright, David W.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (07) : 847 - 857
  • [8] Safety and feasibility of minocycline in treatment of acute traumatic brain injury
    Meythaler, Jay
    Fath, John
    Fuerst, Darren
    Zokary, Hashem
    Freese, Kristina
    Martin, Heidi Baird
    Reineke, Joshua
    Peduzzi-Nelson, Jean
    Roskos, P. Tyler
    [J]. BRAIN INJURY, 2019, 33 (05) : 679 - 689
  • [9] Nutritional treatment for acute and chronic traumatic brain injury patients
    Curtis, L.
    Epstein, P.
    [J]. JOURNAL OF NEUROSURGICAL SCIENCES, 2014, 58 (03) : 151 - 160
  • [10] Inhibition of caspase-mediated apoptosis by peroxynitrite in traumatic brain injury
    Lau, Anthony
    Arundine, Mark
    Sun, Hong-Shuo
    Jones, Michael
    Tymianski, Michael
    [J]. JOURNAL OF NEUROSCIENCE, 2006, 26 (45): : 11540 - 11553